fluoxymesterone (Compound)

Synonyms:fluoxymesterone, 76-43-7, Halotestin, Fluoximesterone, Fluoxymestrone, Androfluorene, Androfluorone, Fluotestin, Android-f, Ora-Testryl, Androsterolo, Fluosterone, Flusteron, Flutestos, Oralsterone, Oratestin, Testoral, Ultandren, Ultandrene, Fluoximesteronum, Neo-Ormonal, Ora Testryl, Fluoximesterona, Fluossimesterone [DCIT], Fluoxymesteronum, Fluoxymesteronum [INN-Latin], Fluoximesterona [INN-Spanish], NSC-12165, Fluoxymesteron, (8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one, 9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone, 9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one, Fluoxymesterone ciii, U 6040, NSC 10704, NSC-10704, Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-, 9JU12S4YFY, CHEBI:5120, FXM, DTXSID8033512, Anadroid-F, 17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone, component of Halodrin, Fluossimesterone, (11beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one, 11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one, 9.alpha.-Fluoro-11.beta.-hydroxy-17-methyltestosterone, DTXCID6013512, Androxy, 9alpha-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one, 9.alpha.-Fluoro-11.beta.,17.beta.-dihydroxy-17.alpha.-methyl-4-androstene-3-one, CAS-76-43-7, Halotestin (TN), (8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, CCRIS 9036, HSDB 3333, EINECS 200-961-8, Testosterone, 9-fluoro-11.beta.-hydroxy-17-methyl-, UNII-9JU12S4YFY, BRN 2008796, 9-alpha-Fluoro-11-beta-hydroxy-17-methyltestosterone, 17-alpha-Methyl-9-alpha-fluoro-11-beta-hydroxytesterone, AI3-52940, 9-Fluoro-11-beta,17-beta-dihydroxy-17-methylandrost-4-en-3-one, Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11.beta.,17.beta.)-, 9alpha-Fluoro-17alpha-methyl-11beta,17-dihydroxy-4-androsten-3-one, NCGC00182970-01, 11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one, 9-alpha-Fluoro-17-alpha-methyl-11-beta,17-dihydroxy-4-androsten-3-one, 9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methyl-4-androstene-3-one, Androxy (TN), 11-beta,17-beta-Dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one, 9-alpha-Fluoro-11-beta,17-beta-dihydroxy-17-alpha-methyl-4-androstene-3-one, Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11beta,17beta)-, Fluoxymesterone [USP:INN:BAN:JAN], Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3 [French], Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl-, Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3, SCHEMBL5096, CHEMBL1445, FLUOXYMESTERONE [MI], FLUOXYMESTERONE [INN], FLUOXYMESTERONE [JAN], 4-08-00-02057 (Beilstein Handbook Reference), MLS001055414, FLUOXYMESTERONE [HSDB], FLUOXYMESTERONE [VANDF], GTPL2861, FLUOXYMESTERONE [MART.], FLUOXYMESTERONE [WHO-DD], BDBM18189, Fluoxymesterone (JAN/USP/INN), HMS2272B06, BCP10776, NSC10704, NSC12165, Tox21_113158, Tox21_200854, 9-fluoro-11beta,17beta-dihydroxy-17alpha-methylandrost-4-en-3-one, FLUOXYMESTERONE [ORANGE BOOK], LMST02020025, FLUOXYMESTERONE CIII [USP-RS], AKOS015895109, Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl- (VAN), DB01185, FLUOXYMESTERONE [USP MONOGRAPH], Fluoxymesterone, solid (photosensitive), NCGC00091037-01, NCGC00091037-02, NCGC00258408-01, AC-29744, SMR000686158, Fluoxymesterone 1.0 mg/ml in Acetonitrile, D00327, A838701, Q410663, W-104363, (1R,2S,10S,11S,14S,15S,17S)-1-fluoro-14,17-dihydroxy-2,14,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one, (8S,9R,10S,11S,13S,14S,17S)-9-fluoranyl-10,13,17-trimethyl-11,17-bis(oxidanyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
Pubchem:PUBCHEM:6446
Id:892124e1-9249-5f56-886b-55e17403d8c7
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View fluoxymesterone's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for fluoxymesterone.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with fluoxymesterone.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.